United States · FDA National Drug Code directory
Pradaxa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0597-0108_ecf1aa06-c610-4fdb-a380-2e716d7e63c2
- Product NDC
- 0597-0108
- Form
- CAPSULE
- Composition / generic term
- dabigatran etexilate mesylate
- Labeler
- Boehringer Ingelheim Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20151123
- Source listing expiry
- 20261231
Source-listed ingredients
- DABIGATRAN ETEXILATE MESYLATE — 110 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0597-0108-54) / 60 CAPSULE in 1 BOTTLE · 0597-0108-54
- 10 BLISTER PACK in 1 CARTON (0597-0108-60) / 6 CAPSULE in 1 BLISTER PACK · 0597-0108-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →